Lower serum interleukin‐22 and interleukin‐35 levels are associated with disease status in neuromyelitis optica spectrum disorders

摘要

The exact pathogenesis of neuromyelitis optica spectrum disorder (NMOSD) remains unclear. A variety of cytokines are involved, but few studies have been performed to explore the novel roles of interleukin‐22 (IL‐22) and interleukin‐35 (IL‐35) in NMOSD. Therefore, this study was designed to investigate serum levels of IL‐22 and IL‐35, and their correlations with clinical and laboratory characteristics in NMOSD.